Replies to post #152202 on Cytodyn Inc (CYDY)

[DonDonDonDon]

"All-cause mortality among critically ill patients was 28% (12/43) with leronlimab + SoC

and 37% (7/19) with placebo + SoC

at day 28 (Table4-6).

This
is approximately a 24% relative reduction in mortality."

The numbers are Tiny Tiny -- such that
ONE patient JUST ONE out of 19 makes a difference.

6/19 in the placebo group would have been 31.5%,

Which when you consider 19 patients its simply NOT different from 28 %

If the whole improvement comes down to one patient, it's pretty much impossible to rule out chance.

This is a nothing. An absolute nothing.

Mic drop

[kgromax]

Excellent synthesis. Goes straight to the meat.

Cytodyn is a fraud and Leronlimab is saline.
Money invested now will be lost. It’s just a question of time IMO.

3rd time I made a bundle thanks to this fraud. Clockwork.

It’s the Nader Constant Failure Model.

[clambottler]

REPORTED ! CEO NADER SPOTTED PUTTING ON HIS

FLEECE JACKET

Explaining the Results and the CYDY Benefit !!!

In the Light Most Favorable - setting aside failure in all endpoints
And setting aside the tricky small print language of ' commonly used treatment ' or such other nonsense the thing is filled with.

Let us take CYDY Greatest Claim to Fame - cutting out the fat and the rancid,

let us look at the Meat they say is good to eat.

"All-cause mortality among critically ill patients was 28% (12/43) with leronlimab + SoC

and 37% (7/19) with placebo + SoC

at day 28 (Table4-6).

This
is approximately a 24% relative reduction in mortality."

The numbers are Tiny Tiny -- such that
ONE patient JUST ONE out of 19 makes a difference.

6/19 in the placebo group would have been 31.5%,

Which when you consider 19 patients its simply NOT different from 28 %

If the whole improvement comes down to one patient, it's pretty much impossible to rule out chance.

This is a nothing. An absolute nothing.

And the trial has to be redone with new patients and new endpoints.

NOW add in the claim they will fill this trial in months ?

Seems highly unlikely.

1.SUMMER is coming - we had a big reduction last summer

2. COMPETITION is everywhere - people have choices

3. VACCINES are taken by a high portion of the population

4. SOC changed Standard of Care changed - you are getting a lot less Critical


Each of the 4 items contributes to a reduced critical patient count.


So Good Luck.


$ .85 -===> the price currently ( $2.1600 ) gives the CYDY company a 1.3 billion market cap
they are worth around Maybe Maybe (many other better companies with greater pipelines are valued at ) $ 500 million.

ADD IN:

5. They need money desperately - they do not have money to do more trials

6. The insiders are apparently selling, removing the legends from the restricted shares

7. They already filed an S-3 to sell up to $ 200,000,000 worth of shares - filed on March 03.


ADD UP 1 - 7:


$ .85 is a very reasonable and rational estimate of the price in 3 months or less ( should be now ).

xxx.
x.
x.

+++ Posted 03 10
looks like people are starting to realize

CEO NADER SPOTTED PUTTING ON HIS FLEECE JACKET